News
FDA’s low-risk TAVR okay set to propel case volume
August 27, 2019
The FDA’s approval of TAVR for low-risk patients should boost both case numbers and U.S. TAVR sites.
News
CPAP safety for infants with bronchiolitis on the general pediatrics floor
August 26, 2019
SEATTLE – “Very, very few” hospitals do bronchiolitis CPAP outside of the ICU.
News
Anticoagulant therapy for AFib in patients with end-stage renal disease
August 23, 2019
Apixaban may be safer than warfarin for patients who have ESRD and who plan for anticoagulation because of AFib.
News
FUO, pneumonia often distinguishes influenza from RSV in hospitalized young children
August 22, 2019
LJUBLJANA, SLOVENIA – “These findings open new possibilities for antimicrobial stewardship in these groups of virally infected children.” Dr. Cihan Papan.
News
Treating children with Kawasaki disease and coronary enlargement
August 22, 2019
An important new study reveals a treatment protocol that decreases the rate of aneurysm enlargement.
News
Dapagliflozin meets primary endpoint in the DAPA-HF trial
August 21, 2019
AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
News
New biomarker model outmatches conventional risk factors for predicting mortality
August 20, 2019
Although the majority of these biomarkers have been associated with mortality before, this is the first study that shows their independent effect when combined into one model.
News
FDA approves Xenleta for community-acquired bacterial pneumonia treatment
August 20, 2019
The approval was based on results from two trials with a total of 1,289 patients.
News
Short-term parenteral antibiotics effective for bacteremic UTI in young infants
August 20, 2019
No significant differences in urinary tract infection recurrence or hospital reutilization between short- and long-term parenteral antibiotic groups.
News
Post-TAVR anticoagulation alone fails to cut stroke risk in AFib
August 19, 2019
By contrast, antiplatelet therapy linked to reduced risk of stroke, whether or not oral anticoagulation was used in this PARTNER II substudy.